The Product Development Core (PDC) is focused on facilitating the product development activities of the three major projects of the Center, and by extension, the services and work performed by the other Cores. The PDC will accomplish this through effective implementation of processes and infrastructure that includes training at every site for all Projects and Cores of the Center.
The Specific Aims for the PDC involving all participating sites of the Center are: 1. Implementation of a product development process with well-defined milestones denoting transition points within the process that include concept, feasibility, development, manufacturing, and clinical validation. 2. Establishment of a Consortium Program Management Committee with representation from all Projects and Cores to guide and manage at a high level all projects within the program. 3. Establishment of Project Development Teams comprised of individuals who are stakeholders in each project. 4. Project management implementation using Microsoft Project software as the standard for facile use and access to project plans with associated timelines, milestone/task deliverables, resource allocations, and project budget planning and monitoring. 5. Implementation of Six Sigma tools for quality product development (Value Stream Mapping, Design of Experiment, and Statistical Process Control). 6. Electronic document standardization for the entire program. 7. Centralized document control using a SQL database that is accessed through a business process management software package for secure revision control, electronic signatures, tracking operational and performance metrics, and auditing for corporate review and regulatory compliance. In short, the PDC will provide significant benefit to the Center's program by ensuring timely delivery of high quality products. In addition, the implemented quality systems will greatly facilitate the transfer of the developed diagnostic devices to manufacturers in a form that can be easily adapted to their manufacturing processes and that is ready for submission for FDA registration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI067773-03
Application #
7470137
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$521,953
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Laiakis, Evagelia C; Mak, Tytus D; Strawn, Steven J et al. (2018) Global metabolomic responses in urine from atm deficient mice in response to LD50/30 gamma irradiation doses. Environ Mol Mutagen 59:576-585
Eppensteiner, John; Davis, Robert Patrick; Barbas, Andrew S et al. (2018) Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults. Front Immunol 9:190
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Lacombe, Jerome; Sima, Chao; Amundson, Sally A et al. (2018) Candidate gene biodosimetry markers of exposure to external ionizing radiation in human blood: A systematic review. PLoS One 13:e0198851
Lee, Younghyun; Pujol Canadell, Monica; Shuryak, Igor et al. (2018) Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep 8:13557
Rudqvist, Nils; Laiakis, Evagelia C; Ghandhi, Shanaz A et al. (2018) Global Gene Expression Response in Mouse Models of DNA Repair Deficiency after Gamma Irradiation. Radiat Res 189:337-344
Suresh Kumar, M A; Laiakis, Evagelia C; Ghandhi, Shanaz A et al. (2018) Gene Expression in Parp1 Deficient Mice Exposed to a Median Lethal Dose of Gamma Rays. Radiat Res 190:53-62
Zheng, Zhihong; Fan, Shengjun; Zheng, Jing et al. (2018) Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. J Hematol Oncol 11:29
Beach, Tyler A; Groves, Angela M; Johnston, Carl J et al. (2018) Recurrent DNA damage is associated with persistent injury in progressive radiation-induced pulmonary fibrosis. Int J Radiat Biol 94:1104-1115
Ghandhi, Shanaz A; Turner, Helen C; Shuryak, Igor et al. (2018) Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells. PLoS One 13:e0191402

Showing the most recent 10 out of 185 publications